EU regulator could issue decision on Pfizer Covid pill 'within weeks'
Published
The approval sought is for the treatment of mild-to-moderate Covid-19 in patients 12 years of age and older, weighing at least 40 kilograms and are at high risk of their illness worsening, the European Medicines Agency said.
Full Article